Robbins Geller, Pomerantz To Lead AstraZeneca Investor Suit
Robbins Geller Rudman & Dowd LLP and Pomerantz LLP have been tapped to represent AstraZeneca investors in a Manhattan federal court suit alleging the company withheld information about problems in the...To view the full article, register now.
Already a subscriber? Click here to view full article